Wang Y, Chen X, Yuan Y. Antibody Response of a H9 Subtype Avian Influenza Poultry Vaccine on Three Kinds of Wild Birds in Shanghai Zoo. Avian Dis. 2020 Oct 27
A semi-annual immunization with a commercial inactivated H9 subtype avian influenza virus (AIV) vaccine developed for poultry has been used to prevent and control the avian influenza (AI) infections among captured wild birds in Shanghai Zoo. However, the overall safety and effectiveness of the poultry vaccine for housed birds in the zoo remains unclear. To verify the safety and efficacy of the commercial inactivated H9 AI vaccine on zoo birds, and to explore a more reasonable and effective immunization procedure, 48 zoo birds, including11 Oriental white storks, 25 peafowl, and12 silver pheasants were administered the AI vaccine developed for poultry use. Then, the clinical signs of the immunized birds were observed for two weeks, and the antibodies against H9 AI were determined via the hemagglutination inhibition (HI) test. Results showed that no harmful effects related to the vaccination were observed, and the antibody titers of the Oriental white stork, peafowl, and silver pheasants were all higher than 7log2 at 21 days, 30 days, 60 days, 120 days and 180 days post-immunization. For further study, the H9 AIV titers of eleven peafowls and six Oriental storks, which were raised in the nursing ground, were continuously monitored for 15months. All of their antibody titers were above the national standards of China (5log2, GB/T18936-2003), even at 12 months and 15 months post-immunization. We concluded that the commercial inactivated H9 AI vaccine used at the present time in Shanghai Zoo can induce high and prolonged immune responses in vaccinated birds.
See Also:
Latest articles in those days:
- Cross-species spill-over potential of the H9N2 bat influenza A virus 10 hours ago
- Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets 10 hours ago
- Epidemiological characteristics of human infections with avian influenza A(H5N6) virus, China and Laos: A multiple case descriptive analysis, February 2014-June 2023 1 days ago
- Interim Estimates of 2023-2024 Seasonal Influenza Vaccine Effectiveness Among Adults in Korea 1 days ago
- Abundant Intra-Subtype Reassortment Revealed in H13N8 Influenza Viruses 3 days ago
[Go Top] [Close Window]